Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 573,621 4.500% | -646,424![]() (-52.98%) | Filing History |
| 2023-07-07 1:28 pm Sale | 2023-06-30 | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 543,325 4.310% | -500,612![]() (-47.95%) | Filing History |
| 2023-07-03 4:02 pm Purchase | 2023-06-23 | 13G | NEKTAR THERAPEUTICS NKTR | Citadel Advisors LLC | 648,650 5.100% | 648,650![]() (New Position) | Filing History |
| 2023-05-05 11:52 am Sale | 2023-04-30 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 1,220,045 9.700% | -1,175,161![]() (-49.06%) | Filing History |
| 2023-04-14 4:34 pm Purchase | 2023-04-04 | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital, LP | 820,149 6.500% | 820,149![]() (New Position) | Filing History |
| 2023-02-09 4:01 pm Sale | 2022-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 1,043,937 8.330% | -116,891![]() (-10.07%) | Filing History |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 1,537,718 12.270% | 303,591![]() (+24.60%) | Filing History |
| 2023-02-06 3:02 pm Sale | 2022-12-30 | 13G | NEKTAR THERAPEUTICS NKTR | Wellington Management Group LLP | 0 0.000% | -758,915![]() (Position Closed) | Filing History |
| 2023-02-02 3:19 pm Purchase | 2023-02-02 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 2,488,498 19.900% | 29,065![]() (+1.18%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 2,395,206 19.100% | 617,086![]() (+34.70%) | Filing History |
| 2022-02-11 12:22 pm Purchase | 2022-02-11 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 2,459,433 20.000% | 95,636![]() (+4.05%) | Filing History |
| 2022-02-10 12:26 pm Sale | 2021-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | PRIMECAP MANAGEMENT CO | 1,160,828 9.430% | -68,532![]() (-5.57%) | Filing History |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 450,614 3.662% | -180,440![]() (-28.59%) | Filing History |
| 2022-02-04 09:29 am Sale | 2021-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Wellington Management Group LLP | 758,915 6.170% | -133,926![]() (-15.00%) | Filing History |
| 2022-01-27 1:59 pm Unchanged | 2021-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 1,778,120 14.500% | 0 (Unchanged) | Filing History |
| 2022-01-25 6:45 pm Purchase | 2021-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | BlackRock Inc. BLK | 1,778,120 14.500% | 552,915![]() (+45.13%) | Filing History |
| 2022-01-10 11:49 am Purchase | 2021-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 1,234,127 10.030% | 149,288![]() (+13.76%) | Filing History |
| 2021-12-10 08:52 am Sale | 2021-12-09 | 13G | NEKTAR THERAPEUTICS NKTR | FMR LLC | 631,054 5.128% | -632,258![]() (-50.05%) | Filing History |

